Phase 1 prospective evaluation of the oncological adequacy of robotic assisted video-endoscopic inguinal lymphadenectomy in patients with penile carcinoma.

Department of Urology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
BJU International (Impact Factor: 3.13). 04/2013; DOI: 10.1111/j.1464-410X.2012.11729.x
Source: PubMed

ABSTRACT WHAT'S KNOWN ON THE SUBJECT? AND WHAT DOES THE STUDY ADD?: Several lymph node staging strategies have been proposed as a response to the high morbidity seen after standard inguinal lymphadenectomy for penile cancer. A video-endoscopic (laparoscopic and robotic) approach has been proposed as a less morbid procedure in several retrospective studies. To date, none has evaluated the oncological adequacy with regard to whether all relevant nodes have been removed. To the authors' knowledge this is the first prospective study of a robotic or laparoscopic inguinal lymphadenectomy that evaluates the oncological adequacy of this approach for penile cancer. The study shows that robotic inguinal lymphadenectomy allowed adequate staging of disease in the inguinal region by removing all relevant lymph nodes as assessed by an independent evaluating urological oncologist. OBJECTIVE: To prospectively determine the oncological adequacy of robotic assisted video-endoscopic inguinal lymphadenectomy (RAVEIL). PATIENTS AND METHODS: Patients with T1-3N0 penile cancer were enrolled into a prospective phase I trial at a tertiary care institution from March 2010 to January 2012. All patients underwent an initial RAVEIL approach. Verification of adequacy of dissection was performed by an independent surgeon via a separate open incision at the conclusion of the RAVEIL procedure. Out of 10 patients, if more than two superficial inguinal fields with ≥2 nodes or more than four with ≥1 node remained within the superficial dissection field, the study would not proceed to phase II. RESULTS: Of 10 enrolled patients two had inguinal metastases and all positive nodes were detected by RAVEIL. The remaining eight patients had no metastases, with a mean of nine (range 5-21) left and nine (range 6-17) right nodes removed. One inguinal field RAVEIL was converted to an open dissection. The verifying surgeon confirmed that 18 of 19 inguinal fields (94.7% in nine patients) had an adequate dissection. Two benign nodes were found just beneath Scarpa's fascia above the inguinal dissection field. Limitations of the study include an inability to determine decisively what specific wound complications were related to RAVEIL because of the protocol-specified creation of a small inguinal incision for verification of adequate dissection. CONCLUSION: RAVEIL allowed adequate staging of disease in the inguinal region among patients with penile cancer at risk for inguinal metastases.

  • [Show abstract] [Hide abstract]
    ABSTRACT: Malignant tumours of the penis are rare tumours. The objective of this article is to propose guidelines for the management of these tumours. A review of the literature was performed by selecting articles on penile cancer published in PUBMED. The most common histological type is squamous cell carcinoma. Clinical examination of the penis is usually sufficient to assess local extension of the primary tumour, but it can be completed by MRI to assess deeper extension. Inguinal lymph nodes must be systematically palpated on both sides to assess regional extension. In the presence of palpable lymph nodes, aspiration cytology is recommended in combination with abdomen and pelvis computed tomography and (18)F-FDG PET-CT. Sentinel lymph node biopsy is recommended in the case of penile cancer at high risk of lymph node extension with no palpable lymph nodes. Treatment of the primary tumour is usually surgical. It must be as conservative as possible while ensuring negative surgical margins. Brachytherapy or local treatment (laser, cytotoxic cream, etc.) can be proposed in some cases. Bilateral lymph node chains must be systematically treated at the time of diagnosis of the disease. Inguinal lymphadenectomy alone has a curative role in patients with metastatic invasion of a single lymph node (stage pN1). In the case of more extensive lymph node involvement, multimodal management combining chemotherapy, surgery and possibly radiotherapy, must be considered. The treatment of penile cancer is usually surgical possibly in combination with chemotherapy in the presence of lymph node extension. The main prognostic factor is lymph node involvement, requiring appropriate management right from the time of diagnosis.
    Progrès en Urologie 11/2013; 23 Suppl 2:S135-44. DOI:10.1016/S1166-7087(13)70051-4 · 0.77 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Inguinal lymph node dissection is a diagnostic and potentially curative treatment for penile carcinoma, which has historically been associated with high morbidity rates. This review summarizes the initial outcomes of robotic-assisted inguinal lymphadenectomy (RAIL) compared with the outcomes of the standard open and endoscopic approaches. The early experience suggests that RAIL may yield comparable oncologic outcomes, although future prospective studies of RAIL with greater numbers of participants and long-term follow-up are needed to evaluate the incidence and severity of perioperative and postoperative complications.
    Current Urology Reports 06/2014; 15(6):412. DOI:10.1007/s11934-014-0412-7
  • [Show abstract] [Hide abstract]
    ABSTRACT: Purpose of review To highlight the recent treatment recommendations that are proposed to improve the outcomes of patients with advanced penile cancer. Recent findings Penile cancer is a rare disease that presents with many diagnostic and treatment specificities. Adequate treatment requires interdisciplinary discussions involving urologist oncologists, medical oncologists and radiation oncologists as well as many other health professionals. Localized disease can now be adequately treated with many different penile-sparing approaches associated with close surveillance. However, many patients present with high-risk features associated with an unfavorable outcome. Recent data and multiple interdisciplinary collaborative groups have fueled a more standardized approach to the treatment of these patients, leading to better survival outcomes and improved quality of life. This review will focus on the recognition of high-risk disease; the indications of lymph node dissections and minimally invasive surgical approaches; the role of neoadjuvant therapy in the setting of advanced lymph node involvement as well as the potential role of targeted therapy for the salvage treatment of metastatic disease. Summary Improved outcomes in advanced penile cancer requires an integrated approach, including better identification of high-risk disease, use of novel dynamic sentinel lymph node identification techniques and use of neo-adjuvant chemotherapy in selected patients with advanced lymph node involvement. Such cases should preferentially be managed by a dedicated interdisciplinary team.
    Current Opinion in Supportive and Palliative Care 07/2014; 8(3). DOI:10.1097/SPC.0000000000000075